This clearance mechanism has also been described in the context of different cellular stressors leading to PS exposure, e.g., hyperosmotic stress [217], plasmodium infection [77], oxidative stress [72], and, to some extent, also ageing of erythrocytes [218]
Both are prescriptiononly compounds typically compounded by pharmacies
Clinicians may also consider collaborating with obesity medicine clinics or utilizing educational resources from the Obesity Medicine Association
Myth #11: Its Not FDA Approved So It Must Be Unsafe The Claim: Retatrutide isnt approved yet which proves its dangerous, thats why FDA wont approve it (Facebook comment) The Reality: FDA approval status reflects where in the approval process a medication sits, not a safety judgment
The lean mass loss seen in GLP-1 trials is in the range expected for the magnitude of weight loss